Lobbying client · LD-2 disclosures
Nephron Pharmaceuticals Corporation
South Carolina
28 filings from 1 registrant · 2018–2026 · latest filed Jul 20, 2026
Reported on its behalf
$1.1M
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$1.1M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
20 filings
$885K on those filings
Manufacturing
MAN
15 filings
$675K on those filings
Pharmacy
PHA
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- ALEXANDER NICHOLAS VOGEL sr The Vogel GroupCovered position: Former Chief Counsel, Senate Majority Leader Bill Frist27 filingsthrough 2026
- Samir N Kapadia The Vogel Group21 filingsthrough 2022
- Brian Marshall Johnson The Vogel GroupCovered position: Former Director of Federal Affairs at the American Petroleum Institute13 filingsthrough 2021
- Jennifer Mallard The Vogel GroupCovered position: Health Policy Advisor to Chief Deputy Whip and House Energy and Commerce Committee Member Rick Lazio (R-NY)
The filings
The 20 most recent of 28 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: nephron-pharmaceuticals-corporation.